Today, the Board of National Breast Cancer Foundation (NBCF) welcomes and congratulates Associate Professor Cleola Anderiesz on her appointment as the Foundation’s new Chief Executive Officer.
With over 20 years of experience across research, academic, not-for-profit and public sectors, Associate Professor Anderiesz brings significant scientific and organisational leadership as well as cross-sectoral partnership skills to the role. Her most recent position is as deputy CEO, Cancer Australia.
Cleola holds a PhD in Medicine, Senior Executive MBA, an honours degree in Science, qualifications in health economics and is a graduate of the Australian Institute of Company Directors.
NBCF has a 27-year legacy and a trusted reputation of national leadership in funding world-class game-changing breast cancer research. NBCF has an ambitious mission to stop deaths from breast cancer. Research investment is vital as it saves lives. Nine people still lose their life to breast cancer every day in Australia.
“With Associate Professor Anderiesz’s appointment, supported by a highly talented staff, NBCF is now poised to take a giant step forward, to accelerate research progress towards our ambitious mission,” said Professor Zorbas.
“I am delighted and honoured to be appointed as the CEO of the National Breast Cancer Foundation. NBCF has a proud and remarkable history of funding world-leading research that positively impacts on survival and quality of life of Australians diagnosed with breast cancer.
I look forward to working with the Board, the NBCF team, the dedicated breast cancer researchers, our valued supporters, and the incredible breast cancer community to achieve our shared mission of Zero Deaths from breast cancer by 2030.” said Associate Professor Anderiesz.
Associate Professor Cleola Anderiesz will officially take up the NBCF CEO role on 4 April 2022.